NCT02527707View on ClinicalTrials.gov

Titrating-Dose of Lonafarnib in Combination With Ritonavir

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

February 9, 2017

Conditions
Chronic Delta Hepatitis
Interventions
DRUG

lonafarnib

antiviral farnesyltransferase inhibitor

DRUG

Ritonavir

Cytochromes P450 3A4 inhibitor used to boost lonafarnib

Sponsors
All Listed Sponsors
collaborator

Hannover Medical School

OTHER

lead

Eiger BioPharmaceuticals

INDUSTRY